Transarterial chemoembolization of unresectable systemic chemotherapy refractory liver metastases: a retrospective single-center analysis.
Yanqiao RenLei ChenSongjiang HuangChen ZhouJiacheng LiuQin ShiChongtu YangRenwang ChenChuansheng ZhengPing HanBin XiongPublished in: Abdominal radiology (New York) (2021)
TACE is well tolerated and effective in patients with unresectable chemotherapy refractory CRCLM. Meanwhile, the results of this study also indicated that TACE is still a better treatment for these patients.